The humoral response of mRNA COVID-19 vaccine in hematological diseases: The HEMVACO study.

Objectives: The HEMVACO study evaluated the humoral response after mRNA anti-SARS-CoV-2 vaccination in an hematological cohort.

Methods: HEMVACO was a prospective, multicentric study registered in ClinicalTrials.gov, number NCT04852796.

An mtDNA perspective of French genetic variation.

Background: The French has been insufficiently characterized so far for mitochondrial DNA (mtDNA) diversity.

Aims: The study aimed to enhance the information available for the French mtDNA pool and to explore the potential microgeographical differentiation of two French regions selected for their linguistic and historical idiosyncrasies.

Subjects And Methods: A total of 868 samples from 12 different locations in France were collected.